Certificate number:RU.77.99.88.003.Е.008415.08.15
Date of registration and renewal:14.08.2015
Dosage form: & nbspTablets weighing 550 mg.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes Dietary supplements - natural metabolites Dietary supplements - polyphenolic compounds
Classification "Clinical" & nbsp BAA sources of antioxidant substances and substances that affect energy metabolism Supplements that promote the normalization of peripheral (capillary) blood circulation, incl. cerebral
Composition: & nbspIngredients: lutein, ascorbic acid, vitamin E, zeaxanthin, citrus flavonoids, MCC, E464, E463, E171, E553, medium chain triglycerides, E570, E172, E470.
Scope: & nbsp

Biologically active substances, mg / table: lutein - no more than 10,0, flavonoids in terms of luteolin - not less than 3,0, vitamin C - not less than 60,0, vitamin E - not less than 15,0, zeaxanthin - not less than 0.1.

Toxic elements (mg / kg, not more): lead

5,0

Cadmium

1,0

Arsenic

3,0

Mercury

1,0

Microbiological indices: QMAFAnM, CFU / g, not more than

50000

CGB (coliforms), in 0.1 g

not allowed

E.coli in 1.0 g

not allowed

Pathogenic microorganisms, including salmonella in 10.0 grams

not allowed

Yeasts and molds (CFU / g, not more)

100

Pesticides, mg / kg, not more than: HCCH (sum of isomers)

0,1

DDT and its metabolites

0,1

heptachlor and aldrin

not allowed

Ingredients: lutein, ascorbic acid, vitamin E, zeaxanthin, citrus flavonoids, MCC, E464, E463, E171, E553, medium chain triglycerides, E570, E172, E470.

Suggested Usage: & nbspDFor sale to the population as a biologically active food additive - a source of lutein, flavonoids, an additional source of vitamins C and E, containing zeaxanthin
Contraindications:ANDindividual intolerance of components, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store in a place inaccessible to children, at a temperature not exceeding 25 ° C.
Research protocols:EThe Federal Agency for Financial Monitoring of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10-2FTS / 2717 dated 08.07.2015.
Recipient:PSB Healthcare OyPSB Healthcare Oy Finland
Information update date: & nbsp20.05.2016
Instructions
Up